Related by context. All words. (Click for frequent words.) 71 Antiviral Therapy 69 Systemic Lupus Erythematosus SLE 69 Hepatocellular Carcinoma 69 Allergic Rhinitis 69 Rheumatoid 69 Chronic Lymphocytic Leukemia 69 Diabetic Neuropathy 68 lupus erythematosus 68 metastatic malignant 68 Rheumatoid Arthritis RA 68 Preclinical Models 68 Severe Sepsis 67 Myelodysplastic Syndrome 67 Oral Fingolimod 67 Myelodysplastic Syndrome MDS 67 Juvenile Idiopathic Arthritis 67 Myelodysplastic Syndromes 67 Subgroup Analysis 66 Adjuvant Treatment 66 Natalizumab 66 Chronic Sinusitis 66 Leukemias 66 J Am Coll 66 Cutaneous T 66 Non Alcoholic Steatohepatitis 66 Chronic Hepatitis C 66 Prolongs Survival 66 systemic lupus erythematosus 66 Glioblastoma Multiforme 66 Bronchiectasis 66 Malignant Melanoma 66 Chronic Myeloid Leukemia 66 Advanced Renal Cell 66 Investigational Treatment 66 Ischemic 66 Meets Primary Endpoint 66 Treating Chronic 66 Pulmonary Arterial Hypertension 66 Chronic Hepatitis B 66 Clinical Trial Results 66 Hypercholesterolemia 66 Chronic Heart Failure 66 ANN INTERN MED 66 Non Alcoholic Fatty 66 Atypical Hemolytic Uremic Syndrome 65 Lipodystrophy 65 Soft Tissue Sarcoma 65 Pooled Analysis 65 erythematosus 65 Lupus Nephritis 65 Morquio 65 Nilotinib 65 complement inhibitor eculizumab 65 Diabetic Nephropathy 65 Mycophenolate Mofetil 65 Autoimmune Disease 65 HeFH 65 Cardiotoxicity 65 Idiopathic Pulmonary Fibrosis 65 Overactive Bladder 65 Progressive Multifocal Leukoencephalopathy 65 Etanercept 65 Cell Lymphoma 65 Telithromycin 65 Atopic Dermatitis 65 PAOD 65 idiopathic thrombocytopenic purpura ITP 65 Neuropathic Pain 65 Renal Cancer 65 Acute Renal Failure 65 Hepatotoxicity 65 Safinamide 65 Relapsed Refractory 65 Sipuleucel T 65 #-# Full Text 65 Gastric Cancer 65 Phase 2b Study 65 Severe Primary IGFD 65 Cutaneous Melanoma 65 Drug Candidate 65 relapsing multiple sclerosis 65 Study Evaluating 65 Novel Oral 65 B Cell Lymphoma 64 Randomized Phase 64 Heart Failure Patients 64 Myelofibrosis 64 Follicular Lymphoma 64 Severe Asthma 64 Decitabine 64 dyslipidaemia 64 Hepatic Encephalopathy 64 Angioedema 64 Dyslipidemia 64 Thromboembolic 64 PsA 64 systemic lupus erythematosus SLE 64 Renal Cell Carcinoma 64 LHON 64 Bosentan 64 Enzyme Replacement Therapy 64 ANCA associated 64 Relapsing Multiple Sclerosis 64 Major Depressive Disorder MDD 64 Bosutinib 64 Fungal Infections 64 Nesiritide 64 Prospective Randomized 64 Rheumatoid Arthritis Patients 64 Autoimmune Diseases 64 Epratuzumab 64 Systemic Sclerosis 64 Idiopathic Thrombocytopenic Purpura ITP 64 proliferator activated receptor 64 Advanced Melanoma 64 Thiazolidinediones 64 Phase IIa Clinical Trial 64 GW# [003] 64 Clinical Outcome 64 atypical Hemolytic Uremic Syndrome 64 Neovascular Age Related Macular 64 Patients Receiving 64 Trandolapril 64 Nonalcoholic Fatty Liver Disease 64 Chronic Lymphocytic Leukemia CLL 64 Female Sexual Arousal 64 Multiple Myeloma MM 64 Systemic lupus erythematosus SLE 64 ORENCIA ® 64 Esophagitis 64 Liver Failure 64 Fabry Disease 64 juvenile idiopathic arthritis 64 lupus nephritis 64 Candesartan 64 Chemotherapy induced 64 HLA DR4 63 overactive bladder syndrome 63 #:#-# [031] 63 Acute Heart Failure 63 invasive candidiasis 63 myelodysplastic myeloproliferative diseases 63 Hormone Refractory Prostate Cancer 63 Teriflunomide 63 Antipsychotic 63 JAK Inhibitor 63 Phase 2b Clinical Trial 63 hyperprolactinemia 63 psoriatic arthritis PsA 63 Aliskiren 63 sertraline Zoloft 63 polyarticular 63 Pemphigus 63 Ankylosing Spondylitis 63 ACE Inhibitors 63 Investigational Compound 63 chronic rheumatic 63 diabetes mellitus DM 63 Newly Diagnosed Multiple Myeloma 63 Chronic Myelogenous Leukemia 63 Benign Prostatic Hyperplasia 63 J Clin 63 rFVIIa 63 Patients Treated With 63 Tiotropium 63 Thrombotic 63 immune thrombocytopenic purpura 63 Hsp# Inhibitor 63 Inflammatory Markers 63 Pediatric Patients 63 Respiratory Distress 63 Acute Decompensated Heart Failure 63 Solid Tumors 63 Antitumor Activity 63 glucocorticoid induced osteoporosis 63 neurogenic bladder 63 Diabetic Patients 63 familial amyloidotic polyneuropathy FAP 63 Left Ventricular 63 Environ Health Perspect 63 autoimmune thyroid 63 leukemia AML 63 systemic lupus erythematosus psoriasis 63 J Am Acad 63 Diffuse Large B 63 Juvenile Idiopathic Arthritis JIA 63 Growth Hormone Deficiency 63 Transdermal Patch 63 Polycystic Ovary Syndrome 63 Hypertrophy 63 CIMZIA TM certolizumab pegol 63 Investigational Drug 63 Metastatic Colorectal Cancer 63 Short Stature 63 Insulin Resistance 63 Dilated Cardiomyopathy 63 Phase 2a Clinical Trial 63 etanercept Enbrel 63 Dual Antiplatelet Therapy 63 retinal vein occlusion induced 63 Patient Outcomes 63 Chronic HCV 63 Controlled Trial 63 Irritable Bowel 63 Tyrosine Kinase Inhibitor 63 Complicated Skin 63 Degarelix 63 Sjogren Syndrome 63 Anti Tumor 63 Adjunctive 63 Asthma COPD 63 Pharmacokinetic Study 63 Pemetrexed 63 Kinase Inhibitor 63 Mouse Model 63 Systemic Lupus 63 Epstein Barr Virus 63 Adjuvant Chemotherapy 63 Dendritic Cells 63 Occlusive Disease 63 Haptoglobin 63 T1DM 63 Zarnestra 63 Helicobacter pylori eradication 63 mycophenolate mofetil 63 Dasatinib 63 Generalized Anxiety Disorder 63 Parnate 63 Psoriatic Arthritis 63 Pafuramidine 63 Metastatic Prostate Cancer 62 Treatment Outcome 62 SJIA 62 Frontotemporal Dementia 62 Combination Treatment 62 AA Amyloidosis 62 Dapagliflozin 62 Lamotrigine 62 See CLINICAL PHARMACOLOGY 62 constipation predominant irritable bowel 62 chronic idiopathic 62 chronic myeloid 62 MPGN 62 Interferon Beta 62 Gastroparesis 62 Ranolazine 62 leukoencephalopathy 62 Ischemic Stroke 62 Treatment Resistant 62 II Clinical Trial 62 Fingolimod 62 Adenoma 62 Genentech Rituxan 62 Retinitis Pigmentosa RP 62 Valopicitabine 62 Irinotecan 62 Prostatitis 62 pemphigus vulgaris 62 Peripheral Artery Disease 62 EFFEXOR XR 62 bronchial hyperresponsiveness 62 lexidronam injection 62 Respiratory Syncytial Virus 62 Metastatic Melanoma 62 Polyneuropathy 62 Randomized Study 62 Bipolar Mania 62 Metabolic Disorder 62 Alzheimers Disease 62 Combo Therapy 62 Shows Promise Against 62 Cytotoxicity 62 Dose Ranging Study 62 diabetes mellitus T2DM 62 Pivotal Phase 62 Vasculitis 62 Disease Progression 62 Refractory Hodgkin Lymphoma 62 systemic juvenile idiopathic 62 Reminyl galantamine 62 Adalimumab 62 disorder FSAD 62 acetonide FA 62 Nat Genet 62 Hepatitis C Virus 62 Preclinical Study 62 haloperidol Haldol 62 Diabetic Foot Ulcer 62 Newly Diagnosed 62 Ulcerative Colitis 62 Critical Limb Ischemia CLI 62 Adjuvant Therapy 62 Interstitial Cystitis 62 Psychiatric Disorders 62 Autoimmunity 62 Chronic Bronchitis 62 ankylosing spondylitis AS 62 idiopathic thrombocytopenic purpura 62 post transplant lymphoproliferative 62 Eculizumab 62 Pathogenesis 62 Chronic Renal Failure 62 anterior uveitis 62 Knee Osteoarthritis 62 Suppl. 62 Invasive Breast Cancer 62 HIV HCV coinfected 62 Syncria R 62 Initiate Phase 62 HER2 Positive Breast Cancer 62 pancytopenia 62 Aurora Kinase 62 Chronic Fatigue Syndrome CFS 62 Hypoparathyroidism 62 Placebo Controlled Study 62 Iron Overload 62 diarrhea predominant irritable 62 MELAS 62 Chronic Rhinosinusitis 62 Thromboembolism 62 Neoplasms 62 Community Acquired Pneumonia 62 AAT deficiency 62 diabetic gastroparesis 62 lichen planus 62 Slow Progression 62 Etiology 62 SSc 62 Neuroprotective Effects 62 Renal Function 62 Interferon Alpha 62 Endometrial Cancer 62 Phase III Trial 62 bullous 62 Ziprasidone 62 autoantibody positive 62 Pegylated Interferon 62 Iron Deficiency Anemia 62 Chronic Inflammatory 62 Heterozygous Familial Hypercholesterolemia 62 Idiopathic 62 Interferon Alfa 62 Hyperkalemia 62 Acute Ischemic Stroke 62 Efficacy Trial 62 Cimzia ® certolizumab pegol 62 Initiates Clinical Trial 62 Myocardial Ischemia 62 J Pediatr 62 Improved Survival 62 Atomoxetine 62 Treated Patients 62 Chemokine Receptor 62 Phase 2a Trial 62 Drug Prevents 62 ara C 62 patientswith 62 TMS Therapy 62 Hematologic 62 Randomized Controlled Trials 62 Chronic Pelvic Pain 62 Biologic Therapy 62 Inflammatory Diseases 62 PEGylated anti 62 Irritable Bowel Syndrome IBS 62 ST Elevation Myocardial 62 dual endothelin receptor antagonist 62 Relapsing Remitting Multiple Sclerosis 62 Teriparatide 62 transthyretin TTR mediated amyloidosis 62 Anticancer Agent 62 Hypertrophic 62 chronic thromboembolic pulmonary 62 INSPIRE Trial Phase III 62 Beta Blocker 62 Cognitive Impairment 62 Chronic Prostatitis 62 gastrin analogue TT 62 Demonstrates Efficacy 62 Lubiprostone 61 Paroxysmal Nocturnal Hemoglobinuria PNH 61 abacavir Ziagen 61 Receives Orphan Drug Designation 61 Clinical Trial Data 61 Bazedoxifene 61 Microalbuminuria 61 Suicidality 61 Postmenopausal Women 61 Renal Impairment 61 Bicalutamide 61 leukemia ALL 61 Hypertriglyceridemia 61 Glioma 61 visilizumab 61 Cachexia 61 peritumoral brain edema 61 Unstable Angina 61 Naive Patients 61 INS# [001] 61 Patient Registry 61 Randomized Double blind 61 Adenomas 61 Pivotal Phase III 61 Denufosol 61 #:#-# [023] 61 Combination Therapy 61 Kepivance 61 Lenalidomide 61 Hypotension 61 Diabetic Retinopathy 61 Dupuytren Contracture 61 Retreatment 61 Inhaled Corticosteroids 61 Bucindolol 61 Pancreatitis 61 Sapacitabine 61 Infarct 61 acute myeloid 61 Thrombocytopenia 61 thiazolidinedione TZD 61 Protease Inhibitors 61 Renal Cell Carcinoma RCC 61 efalizumab 61 Respiratory Virus 61 Immunosuppression 61 Hematological 61 purpura ITP 61 aMCI precursor 61 either acutely decompensated 61 polycythemia vera essential thrombocythemia 61 Disease Modifying 61 Sclerosing 61 Randomized Double Blind 61 Patency 61 Plaque Psoriasis 61 SPRYCEL ® 61 Peripheral Arterial 61 pan HDAC inhibitor 61 Microplasmin 61 Venous Thromboembolism 61 J Am Soc 61 MGd 61 pouchitis 61 progressive neurodegenerative disorder 61 Treatment Shows Promise 61 Adjunctive Therapy 61 Squamous 61 Emerging Therapies 61 Elderly Patients 61 Risk Stratification 61 Beta Amyloid 61 Survival Benefit 61 Arch Intern Med 61 refractory gout 61 Mg Usa 61 Lymphocytic 61 T2DM 61 Immune Thrombocytopenic Purpura ITP 61 STRIDE PD 61 induce orthostatic hypotension 61 thalidomide Thalomid 61 G6PD deficiency 61 Hepatitis C Genotype 61 Genetic Variation 61 Romiplostim 61 chronic granulomatous disease 61 Therapeutic Effects 61 INTEGRILIN R 61 Antiplatelet 61 Ozarelix 61 Shows Efficacy 61 1 diabetes T1D 61 ritonavir boosted 61 Serious Infections 61 Nebulized 61 severe oral mucositis 61 Phase IIb Trial 61 AAT Deficiency 61 Parathyroid Hormone 61 interleukin IL -# 61 dermatologic reactions 61 FDA Approvals 61 Improve Survival 61 Nephrol Dial Transplant 61 atypical hemolytic uremic syndrome 61 benign prostatic hypertrophy BPH 61 Replacement Therapy 61 Kidney Transplant Patients 61 LYSTEDA 61 Aflibercept 61 Tolvaptan 61 Castration Resistant Prostate Cancer 61 Autologous Stem Cell Transplantation 61 Sezary syndrome 61 Secondary Hyperparathyroidism 61 Dermatol 61 Hemorrhagic Stroke 61 Oral Mucositis 61 Successfully Completes Phase 61 Phase IIA 61 Treatment Naive Patients 61 Endocrinol 61 Arterial Disease 61 Novel Inhibitor 61 CYT# potent vascular disrupting 61 HDAC Inhibitor 61 Polymorphisms 61 Recombinant Human 61 Arthritis Rheum 61 osteoporotic vertebral fractures 61 HER2 overexpression 61 Serious Adverse Events 61 treat benign prostatic 61 Schizoaffective Disorder 61 Well Tolerated 61 kidney urologic 61 painful diabetic neuropathy 61 Ischaemic 61 hypereosinophilic syndrome 61 Associated Adipose Redistribution 61 PEGylated interferon beta 1a 61 Hyperlipidemia 61 Bisphosphonate 61 sodium glucose cotransporter 61 advanced hepatocellular carcinoma 61 Clinical Efficacy 61 chronic GVHD 61 Saxagliptin 61 urticaria hives 61 Lung Injury 61 Obstet Gynecol 61 myeloproliferative neoplasms 61 Phase III Clinical Trials 61 Observational Study 61 Etravirine 61 Trodusquemine MSI 61 seropositive patients 61 Papillary 61 Cytochrome P# 61 Personalized Immunotherapy 61 Preclinical Data 61 Hemorrhagic 61 Hemophilia B 61 Metastatic Renal Cell Carcinoma 61 Acute Coronary Syndromes 61 Iron Deficiency 61 Surgical Treatment 61 haematologic 61 Am J Clin 61 crohn disease 61 Randomized Clinical Trial 61 Infected Patients 61 Malignancies 61 Arch Neurol 61 J Clin Endocrinol Metab 61 treat chronic sinusitis 61 Vascular Dementia 61 Myocardial Infarction 61 mastocytosis 61 Tolerability 61 Mg Uk 61 choriocarcinoma 61 J Foot Ankle 61 gastrointestinal stromal tumors GIST 61 Drug Shows Promise 61 histone deacetylase HDAC inhibitor 61 Completes Patient Enrollment 61 Omacetaxine 61 Chronic lymphocytic leukemia 61 Acute Myeloid Leukaemia AML 61 Scandinavian Simvastatin Survival 61 Patients Treated 61 Neuropathic 61 PHPT 60 Friedreich Ataxia FRDA 60 Pivotal Study 60 catechol O methyltransferase 60 Arteriosclerosis 60 J Allergy Clin 60 Epidermal Growth Factor Receptor 60 endometrial hyperplasia 60 Neuroprotection 60 FluCAM arm 60 Plaquenil 60 Cytomegalovirus 60 tolvaptan 60 Bladder Cancer 60 Fibrosis 60 Tocilizumab 60 Diabetes Mellitus 60 Myeloid 60 Monotherapy 60 PEG IFN 60 Crit Rev 60 Golimumab 60 imatinib Gleevec ® 60 Gastrointestinal GI 60 induced macular edema 60 EGFR HER2 60 Inflammatory Bowel Diseases 60 atherothrombotic disease 60 chronic eosinophilic leukemia 60 ORENCIA R 60 Lymphoid 60 Diagnostic Criteria 60 Improves Outcomes 60 Aortic Stenosis 60 Tasimelteon 60 leiomyomas 60 gefitinib Iressa 60 relapsing remitting MS RRMS 60 Diabetes Hypertension 60 chronic immune thrombocytopenic 60 Carvedilol 60 cinacalcet 60 toenail onychomycosis 60 Predict Risk 60 Cutaneous 60 Tyrosine Kinase Inhibitors 60 Hepatitis C Infection 60 polymyalgia rheumatica 60 metastatic neuroendocrine tumors 60 Pulmonary Arterial Hypertension PAH 60 HBeAg negative 60 Refractory Angina 60 aldosterone antagonists 60 terlipressin 60 Peripheral Arterial Disease 60 Ankylosing spondylitis 60 hepatorenal syndrome 60 Phase III Clinical Trial 60 Hepatitis B Vaccine 60 Nonspecific 60 including thyroiditis RA 60 Therapeutic Targets 60 Vidaza azacitidine 60 liposome injection 60 Pharmacokinetics PK 60 Intervention Effectiveness 60 Central Retinal Vein 60 Major Depressive Disorder 60 Polymerase Inhibitor 60 Catena ® 60 Hypoactive Sexual Desire Disorder 60 Psoriasis Patients 60 Comorbidity 60 dasatinib Sprycel ® 60 Glatiramer Acetate 60 Galantamine 60 Retinopathy 60 Aneurysm Repair 60 bacterial vaginosis BV 60 Pelvic Organ Prolapse 60 Cognitive Deficits 60 CTAP# Capsules 60 Sevelamer 60 Prophylactic Treatment 60 Diabetic Foot Ulcers 60 Peptic Ulcer 60 Fulvestrant 60 Warfarin Coumadin 60 FOLOTYN ® 60 myeloid metaplasia 60 vapreotide acetate 60 constipation OIC 60 extrapyramidal symptoms 60 atrophic gastritis 60 myocardial infarction ventricular fibrillation 60 Zorbtive TM 60 Hodgkin lymphoma HL 60 Immune Mediated 60 Intravitreal 60 ADPKD 60 Lung Cancer Trial 60 Tacrolimus 60 Belimumab 60 Artificial Pancreas 60 erlotinib Tarceva ® 60 Hashimoto thyroiditis 60 colorectal carcinoma 60 Clinical Trial Evaluating 60 Topiramate 60 abstr 60 Immune Thrombocytopenic Purpura 60 Interferon beta 1b 60 Depressive Symptoms 60 overactive bladder symptoms 60 calcineurin inhibitor 60 Breast Cancer Recurrence 60 Dupuytren Disease 60 delta gamma agonist 60 AVAPRO 60 R lenalidomide 60 Enzastaurin 60 Eur J Endocrinol 60 Antifungals 60 macroalbuminuria 60 Meta Analysis 60 Inflammatory Bowel Disease 60 Chronic Constipation 60 Diastolic Heart Failure 60 Psoriatic arthritis 60 CYP #D# 60 uricase 60 Tardive dyskinesia 60 Orally Active 60 Exp Clin 60 SNT-MC#/idebenone 60 Successfully Treated 60 Orthostatic Hypotension 60 Relapsed Multiple Myeloma 60 Sclerosis 60 Arrhythmogenic 60 imipramine Tofranil 60 Prospective Multicenter 60 Malignant Glioma 60 Patients Undergoing 60 disease GERD 60 Lowers Risk 60 Seasonal Allergic Rhinitis 60 Prostatic 60 novel VDA molecule 60 Crohn disease CD 60 Free Full Text 60 Score TOS 60 Behcet Disease 60 Cardiol 60 CIMZIA ™ 60 vWD 60 posaconazole 60 Tumor Progression 60 castrate resistant prostate cancer 60 dyskinesia PD LID 60 Randomized Controlled 60 Inflammatory Arthritis 60 Gene Linked 60 Eye Diseases 60 Stomatitis 60 Pioglitazone 60 Mouse Models 60 Diabetic Neuropathic Pain 60 Chronic Obstructive Pulmonary 60 NAGS deficiency 60 Cardiovascular Outcomes 60 Previously Treated 60 pheochromocytoma 60 Pivotal Trial 60 VAPRISOL 60 aripiprazole Abilify 60 Nitazoxanide 60 Rheumatoid Arthritis 60 lactic acidosis 60 myotonic muscular dystrophy 60 Chronic Myelogenous Leukemia CML 60 Antiepileptic Drugs 60 Anticoagulant 60 Atherosclerotic 60 pathologic myopia 60 Demonstrates Positive 60 immune thrombocytopenic purpura ITP 60 Vaprisol 60 Parkinson disease PD 60 Small Intestine 60 receptor tyrosine kinase inhibitor 60 humanized interleukin 6 60 Telaprevir VX 60 idiopathic myelofibrosis 60 refractory chronic lymphocytic 60 LymphoStat B belimumab 60 Restless Legs Syndrome 60 mycophenolate mofetil MMF 60 keloid scarring 60 urolithiasis 60 basiliximab 60 sJIA 60 Myoblast 60 ß blockers 60 rufinamide 60 Ribavirin causes 60 Anthracycline 60 heFH 60 Keratitis 60 Trigeminal Neuralgia 60 Clinical Trials Review 60 sorafenib tablets 60 Acute Bacterial Sinusitis ABS 60 Cytomegalovirus CMV 60 Cannabinoid 60 FASEB J. 60 capillary leak 60 hyperphenylalaninemia HPA due 60 liposomal amphotericin B 60 Maleate 60 Malignant Pleural Mesothelioma 60 Dose Escalation Study 60 primary Restless Legs 60 Coronary Artery 60 FASLODEX 60 Advanced Pancreatic Cancer 60 Noxafil 60 discoid lupus 60 Amgen Neulasta R 60 Osteomyelitis 60 Janus kinase 60 AFREZZA TM 60 LPS induced 60 Primary IGFD 60 NIDDM 60 Glucocorticoids 60 Novartis Reclast 60 Kidney Function 60 PKC# 60 adalimumab Humira 60 Randomized Comparison 60 Drug Resistant 60 Disorder ADHD 60 Restless Legs Syndrome RLS 60 steroid refractory ulcerative 60 neurological manifestations 60 subependymal giant cell 60 Valsartan 60 antibody MAb 60 SHPT 60 oral candidiasis 60 Kinase Inhibitors 60 alpha interferons 60 Septic Shock 60 glitazones 60 rare autosomal recessive 60 von Willebrand Disease 60 Parkinsonism 60 Skin Lesions 60 Systemic Delivery 60 Evaluation WISE 60 eosinophilic asthma 60 hypovitaminosis D 60 Nocturia 60 Phase Ib Clinical Trial 60 Novel Compound 60 Recurrent Breast Cancer 60 Receptor Agonist 60 Zoloft sertraline 60 rheumatic disease 60 Study Showed 60 Pivotal Trials 60 Parkinson Disease PD 60 Pirfenidone 60 venlafaxine Effexor 60 Ropinirole 60 Traficet EN 60 Novel Mechanism 60 Herpes zoster 60 progressive dyspnea 60 Endocarditis 60 Suppl 60 Oesophageal 60 Hospital Acquired Pneumonia 59 Neoplasia 59 DPNP 59 symptomatic intracranial 59 Intracerebral Hemorrhage 59 Multicenter Randomized 59 cytomegalovirus infection 59 biliary tract cancer 59 GH deficiency 59 Pneumocystis carinii pneumonia 59 Hydroxyurea 59 Curr Opin 59 Reflux Disease 59 hypercholesterolaemia 59 retinal vein occlusion 59 pertuzumab 59 Investigational Agent 59 Bone Metastases 59 alfuzosin 59 Nephrol 59 nephropathic cystinosis 59 Acute Exacerbations 59 acute gout 59 Antigen Specific 59 cerebrovascular disorders 59 Liver Injury 59 Invasive Fungal Infections 59 Inflammatory Disease 59 Orthop Surg 59 J Nutr 59 Transdermal Delivery 59 paroxysmal nocturnal hemoglobinuria 59 Crit Care Med 59 Glypromate 59 Postmenopausal 59 Coronary Artery Bypass Graft 59 occlusion CRVO 59 prokinetic agent 59 systolic hypertension 59 Oral Interferon 59 Peginterferon Alfa 2a 59 post herpetic neuralgia PHN 59 Arrhythmias 59 Fracture Risk 59 Improves Survival 59 Beneficial Effects 59 immunomodulatory therapy 59 Infusion Reactions Severe 59 infliximab Remicade 59 formerly LymphoStat B 59 Metabolic Disease 59 Elagolix 59 Phase IIb Clinical Trial 59 severe malignant osteopetrosis 59 Aviptadil 59 Mantle Cell Lymphoma 59 systemic autoimmune 59 bexarotene 59 Autoantibodies 59 Carcinoma 59 Cilostazol 59 Nonalcoholic fatty liver 59 chronic myocardial ischemia 59 Infantile Spasms 59 neovascular 59 lymphoproliferative disorder 59 Randomized Double Blind Placebo 59 Cell Transplant 59 Phase 2b Trial 59 Mol Cell 59 Pathway Inhibitor 59 Pemphigus Vulgaris 59 Gaucher Disease 59 Glatiramer acetate 59 OMNARIS HFA 59 Non Hodgkin 59 heparin induced thrombocytopenia 59 HCV Genotype 59 rheumatoid arthritis psoriatic arthritis 59 Apaziquone 59 Diabetic Macular Edema 59 Clostridium difficile Infection 59 Muraglitazar 59 essential thrombocythemia 59 INCB# [003] 59 Protease Inhibitor 59 Juvenile Rheumatoid Arthritis 59 Laryngeal Cancer 59 Zeldox 59 Ventricular Tachycardia 59 Patient Enrollment 59 thetreatment 59 Virus Infection 59 persistent pulmonary hypertension 59 Combination REOLYSIN R 59 Dyskinesia 59 Rheumatic Fever 59 hemophilia B. 59 Bulimia Nervosa 59 Xyfid TM 59 Gene Mutation 59 sodium thiosulfate STS 59 oral antidiabetic medication 59 Increased Mortality 59 Initiates Clinical 59 comorbid anxiety 59 Genetic Basis 59 venous thromboembolic disease 59 Candida infection 59 Delayed Graft Function 59 refractory cutaneous T 59 chronic constipation CC 59 MKC# MT 59 erythematosus SLE 59 Long Term Efficacy 59 Niemann Pick disease 59 Interferon alpha 59 Fludarabine 59 Venous thromboembolism 59 Panic Disorder 59 Neurol 59 Artery Disease 59 hepatocellular carcinoma HCC 59 pulmonary arterial hypertension PAH 59 Comorbidities 59 RNAi Therapeutic 59 systemic fungal infections 59 Metastatic breast cancer 59 Cushing syndrome 59 familial hypercholesterolemia 59 orally inhaled migraine 59 Haemostasis ISTH 59 Ann Emerg Med 59 Cardiovascular Mortality 59 Immune Responses 59 Overactive Bladder OAB 59 cytopenia 59 Sexual Dysfunction 59 candesartan cilexetil 59 Diabetes mellitus 59 Factor VIIa 59 Anticancer Drugs 59 Osteoporotic